Valuation: Oscotec Inc.

Market Cap 1,153B 776M 678M 626M 577M 1.09B 74.7B 1.11B 7.48B 2.94B 36.59B 2.91B 2.85B 126B P/E 2026 *
35.9x
P/E 2027 * 9.66x
Enterprise Value 968M 651K 569K 525K 484K 912K 62.72M 933K 6.28M 2.47M 30.72M 2.45M 2.39M 106M EV / Sales 2026 *
11.5x
EV / Sales 2027 * 4.42x
Free-Float
71.79%
Yield 2026 *
-
Yield 2027 * -
1 day-1.31%
1 week-2.90%
Current month-16.83%
1 month-23.96%
3 months-44.88%
6 months-31.40%
Current year-33.30%
1 week 27,300
Extreme 27300
31,700
1 month 27,300
Extreme 27300
39,500
Current year 27,300
Extreme 27300
60,200
1 year 27,300
Extreme 27300
66,000
3 years 18,000
Extreme 18000
66,000
5 years 15,850
Extreme 15850
66,000
10 years 5,630
Extreme 5630
71,500
Manager TitleAgeSince
Chief Executive Officer 63 2020-03-25
Corporate Officer/Principal 53 1999-08-31
Chief Tech/Sci/R&D Officer 62 -
Director TitleAgeSince
Director/Board Member 53 1999-08-31
Director/Board Member 63 2020-03-25
Director/Board Member 66 2023-03-29
Date Insider Type Main position Quantity % Market Cap.
7/24/25 Buy 500 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-1.31%-2.90%-12.35%+49.63% 776M
-0.10%+3.21%+59.45%+20.34% 315B
-1.20%-2.43%+23.24%-8.31% 67.81B
+0.35%+2.11%+37.84%+86.59% 9.23B
+0.34%+0.51%+5.21%-0.69% 8.56B
+1.53%-3.64%-22.91%+5.31% 4.18B
-11.03%-12.07%-8.02%+14.00% 3.59B
+1.87%+3.36%-46.36%+28.62% 3.55B
-0.35%-0.87%+48.55%+60.56% 2.79B
-7.41%-2.37%+3.91%-23.64% 2.09B
Average -1.73%-1.84%+8.85%+23.24% 41.75B
Weighted average by Cap. -0.36%+1.01%+49.19%+16.69%

Financials

2026 *2027 *
Net sales 84B 56.49M 49.37M 45.55M 41.99M 79.14M 5.44B 80.9M 544M 214M 2.66B 212M 207M 9.17B 192B 129M 113M 104M 95.98M 181M 12.43B 185M 1.24B 490M 6.09B 485M 474M 20.96B
Net income 32B 21.52M 18.81M 17.35M 16M 30.15M 2.07B 30.82M 207M 81.58M 1.01B 80.82M 79.04M 3.49B 119B 80.03M 69.94M 64.53M 59.48M 112M 7.71B 115M 771M 303M 3.77B 301M 294M 12.99B
Net Debt -185B -124M -109M -100M -92.48M -174M -11.98B -178M -1.2B -472M -5.87B -467M -457M -20.2B -304B -204M -179M -165M -152M -286M -19.69B -293M -1.97B -775M -9.64B -768M -751M -33.19B
Logo Oscotec Inc.
Oscotec Inc is a Korea‑based company primarily engaged in new drug development business. The Company operates four main businesses. The new drug development business primarily mainly researches and develops synthetic new drugs, including therapies for autoimmune diseases, acute myeloid leukemia, refractory solid tumors, Alzheimer’s disease and next‑generation solid tumor treatments designed to overcome drug resistance. The dental bone graft business primarily supplies bone graft materials. The dental barrier membrane business provides own developed absorbable collagen barrier membranes. The functional materials and related products business primarily provide functional materials for osteoporosis prevention and bone health, materials and finished products for arthritis prevention and alleviation, and functional materials for periodontal disease prevention and alleviation.
Employees
55
Date Price Change Volume
26-07-16 ₩30,150.00 -1.31% 110,418
26-07-15 ₩30,550.00 +9.11% 165,409
26-07-14 ₩28,000.00 -5.08% 229,852
26-07-13 ₩29,500.00 -4.99% 221,418
26-07-10 ₩31,050.00 -0.48% 187,923
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
30,150.00KRW
Average target price
75,000.00KRW
Spread / Average Target
+148.76%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A039200 Stock